More than 40 million Americans take glucosamine every year. It is the fourth most widely used supplement in the United States, sold on every pharmacy shelf and recommended across hundreds of wellness websites as a safe, natural remedy for joint pain and osteoarthritis.
On June 9, 2026, a team of neuroscientists at the University of Florida published findings that could change that conversation entirely.
Their study, published in Nature Metabolism, one of the most prestigious scientific journals in the world, analyzed medical records from over 65,000 patients, 24,000 with dementia and 41,000 with mild cognitive impairment, and combined that data with advanced brain tissue imaging and Alzheimer’s mouse models. The conclusion: glucosamine supplementation is associated with a 25% higher likelihood that a person with mild cognitive impairment will progress to dementia and Alzheimer’s disease.
Among patients who already had Alzheimer’s or related dementias, glucosamine use was linked to a 25% increase in mortality risk over a ten-year survival analysis.
“A lot of these people actively take an over-the-counter supplement that could be making their disease progression worse,” said senior author Dr. Ramon Sun, director of the Center for Advanced Spatial Biomolecule Research at the University of Florida.
This article breaks down what the study found, how glucosamine interacts with your brain, who is most at risk, and what safer alternatives exist for managing joint pain. If you or someone you love takes glucosamine, especially alongside any signs of cognitive decline, this is essential reading.
What the Study Found: The 25% Risk Increase
The University of Florida research team, led by Dr. Ramon Sun and co-authored by Dr. Matt Gentry, chair of the university’s biochemistry and molecular biology department, conducted what they describe as the first integrated analysis combining large-scale patient health records with spatial multiomics, spatial isotopic tracing, and glycomics of human brain tissue.
Here is what they found, broken into clear outcomes.
Progression from Mild Cognitive Impairment to Dementia
Among the 41,000 patients with mild cognitive impairment (MCI), the earliest clinically recognized stage of memory loss, those who reported taking glucosamine were 25% more likely to progress to full Alzheimer’s disease than those who did not take the supplement.
MCI is a critical window. Not everyone with mild cognitive impairment develops Alzheimer’s. Many stabilize, and some even improve. Any factor that tips the odds toward progression is clinically significant, especially one taken voluntarily as an over-the-counter supplement. Understanding the full range of conditions that can interact with cognitive health is becoming increasingly important as the population ages.
Mortality in Established Dementia Patients
Among the 24,000 patients with diagnosed Alzheimer’s disease or related dementias, glucosamine supplementation was associated with a 25% higher mortality risk over a ten-year follow-up period compared to patients who did not use the supplement.
Importantly, this mortality increase was not observed in the MCI group alone, suggesting that established dementia may create a more vulnerable biological environment where glucosamine’s effects become more dangerous.
Mouse Model Confirmation
The researchers did not rely solely on health records. They also tested glucosamine directly in Alzheimer’s mouse models (5xFAD mice, a widely used transgenic model). Oral glucosamine supplementation worsened memory deficits in these mice. Conversely, when the researchers genetically knocked down the enzymes responsible for the sugar-tagging process that glucosamine fuels, cognitive outcomes improved.
This combination of human observational data and mechanistic animal evidence is what gives the study its weight. Most supplement risk studies rely on only one type of evidence. This study triangulated three: health records, human brain tissue imaging, and controlled animal experiments.
How Glucosamine Crosses the Blood-Brain Barrier and Fuels Disease
This is where the science gets fascinating, and where this study breaks genuinely new ground.
Glucosamine is an amino sugar, a naturally occurring compound found in the cartilage that cushions your joints. When you swallow a glucosamine supplement, your body absorbs it through the gut, and it enters the bloodstream. So far, nothing unusual. Most vitamins and supplements follow a similar path.
But glucosamine does something many supplements do not: it crosses the blood-brain barrier, the tightly regulated membrane that controls which substances can enter your brain from your bloodstream. Once inside the brain, glucosamine feeds directly into a metabolic process called glycosylation, the attachment of sugar molecules (glycans) to proteins.
Glycosylation is a normal and essential cellular process. Your cells glycosylate proteins all the time as part of healthy function. But in the brains of people with Alzheimer’s disease, the University of Florida researchers discovered something abnormal: a state they call hyperglycosylation, where this sugar-tagging pathway is dramatically overactive.
Using advanced spatial metabolomics (technology that maps the precise location of metabolic activity within brain tissue), the team showed that Alzheimer’s brains produce far more N-linked glycans than healthy brains. This excessive glycan production is driven by increased activity in the glycan biosynthesis pathway, the very same pathway that glucosamine feeds into.
In simple terms: Alzheimer’s brains already have an overactive sugar-tagging system. Glucosamine adds fuel to that overactive system by providing more raw material for glycan production. The result is accelerated metabolic dysfunction in precisely the brain regions where Alzheimer’s does its damage.
This metabolic connection between sugar processing and neurodegeneration also echoes emerging research on how metabolic disruptions in conditions like Type 2 diabetes can intersect with brain health. The broader gut-brain connection is another area where metabolic pathways influence cognitive function in ways scientists are only beginning to map.
“Our results suggest that altered metabolism is a significant contributor to Alzheimer’s progression and, in addition, addressing the metabolic defect could be an important complement to approaches focused on Alzheimer’s plaques and tangles,” said Dr. Sun.
Perhaps most promisingly, when the researchers blocked the hyperglycosylation pathway in Alzheimer’s mice by genetically knocking down the responsible enzymes, the cognitive deficits completely reversed. This suggests the pathway itself may be a viable therapeutic target for future Alzheimer’s treatments, entirely separate from the amyloid plaque-focused approaches that have dominated drug development for decades.
Who Is Most at Risk?
The study’s findings do not suggest that glucosamine is equally dangerous for everyone. The researchers were careful to note that the risks appear to be concentrated in people whose brains are already experiencing neurodegeneration.
People with Mild Cognitive Impairment (MCI)
This group showed the 25% higher rate of progression to full Alzheimer’s. MCI is characterized by noticeable memory or thinking problems that are greater than expected for a person’s age but do not yet interfere significantly with daily life. An estimated 12 to 18 percent of adults over 60 have some form of MCI, though many are undiagnosed.
If you have been told you have mild cognitive impairment, or if you have noticed increasing forgetfulness, difficulty following conversations, or trouble with planning and organization, this finding is directly relevant to you.
People with Diagnosed Alzheimer’s or Related Dementias
This group showed both the 25% higher progression rate and the 25% higher mortality risk. About 6.7 million Americans currently live with Alzheimer’s, with millions more affected by related dementias such as Lewy body dementia or frontotemporal dementia. The researchers estimated that approximately 8% of patients with cognitive impairment in their dataset were taking glucosamine, which extrapolates to potentially over one million people nationally who may be unknowingly worsening their condition.
Cognitively Healthy Individuals
The study did not establish that glucosamine poses the same risk to people with no cognitive impairment. The hyperglycosylation mechanism appears to exploit a vulnerability that already exists in neurodegenerating brains. However, the researchers noted that this question needs direct investigation in future studies, and that the findings warrant caution.
Should You Stop Taking Glucosamine?
This is the most important section of this article. The answer requires nuance.
Do not stop any medication or supplement without consulting your healthcare provider. This is always the correct first step, regardless of what any study says.
That said, here is the context you need for that conversation with your doctor.
The study published in Nature Metabolism is observational. It identifies a strong statistical association between glucosamine use and worse outcomes in cognitively impaired populations, and it provides a biologically plausible mechanism (hyperglycosylation) supported by both human brain imaging and animal experiments. That is a powerful combination, stronger than a simple correlation study.
However, it is not a randomized controlled trial. There may be confounding factors the researchers did not fully account for. The results are, in the researchers’ own words, “preliminary and require validation in a human clinical trial.”
What this means practically:
If you have no cognitive symptoms and no family history of Alzheimer’s, the study does not provide definitive reason to stop glucosamine immediately. But it is reasonable to discuss alternative joint pain strategies with your doctor, especially given that glucosamine’s effectiveness for joint pain itself has been debated in the medical literature for years.
If you have mild cognitive impairment, diagnosed dementia, or a strong family history of Alzheimer’s, this study provides a clear signal. Bring the Nature Metabolism paper to your next doctor’s appointment and discuss whether glucosamine’s modest joint benefits are worth the potential cognitive risk. There are effective alternatives.
If a parent or grandparent takes glucosamine and has shown signs of memory decline, consider sharing this article with them and encouraging a medical conversation. This is exactly the kind of finding that matters most when shared with the people who need it.
Safer Alternatives for Joint Pain
The good news: glucosamine is far from the only option for managing joint pain and osteoarthritis. Several alternatives have strong evidence behind them and no known cognitive risks.
Collagen Supplements
Just days before the glucosamine study, the largest collagen review ever conducted was published: an umbrella review of 113 clinical trials involving nearly 8,000 participants, by researchers at Anglia Ruskin University. It found that collagen supplementation significantly reduces osteoarthritis pain and stiffness when taken consistently over time. Hydrolyzed collagen peptides and undenatured Type II collagen both showed benefits through different mechanisms.
This is directly relevant. If you are taking glucosamine for joint pain and are looking for an evidence-based replacement, collagen is now the most thoroughly studied alternative. Our full breakdown is here: Do Collagen Supplements Actually Work? What the Biggest Study Ever Found.
Omega-3 Fatty Acids
Fish oil and omega-3 supplements have documented anti-inflammatory properties supported by multiple meta-analyses. They can reduce joint inflammation, stiffness, and pain in people with osteoarthritis and rheumatoid arthritis. Unlike glucosamine, omega-3s have been associated with neuroprotective benefits in observational studies, making them a particularly sensible swap for people concerned about brain health.
Curcumin (Turmeric Extract)
Curcumin, the active compound in turmeric, has demonstrated anti-inflammatory and antioxidant properties in randomized controlled trials. Several studies have shown curcumin to be as effective as ibuprofen for reducing knee osteoarthritis pain, with fewer gastrointestinal side effects. It is part of a broader category of evidence-backed natural compounds, similar to those explored in our guide to superfoods that actually work.
Physical Therapy and Exercise
Medical guidelines worldwide consistently recommend physical therapy and structured exercise as the first-line treatment for osteoarthritis, ahead of any supplement. Strengthening the muscles around affected joints reduces load on cartilage, improves mobility, and decreases pain. If you are dealing with chronic pain, combining movement-based therapy with evidence-based supplementation offers the most comprehensive approach. For targeted strategies, see our guide to effective tips for relieving lower back pain.
Other Natural Anti-Inflammatory Supplements
Several supplements in BillboardHealth’s existing coverage have documented anti-inflammatory properties relevant to joint health. Ashwagandha has shown benefits for inflammation and stress-related pain pathways. Black seed oil (Nigella sativa) contains thymoquinone, a compound with documented anti-inflammatory effects. These can complement a joint health protocol that does not rely on glucosamine.
An anti-inflammatory plant-based diet rich in fruits, vegetables, nuts, and omega-3 sources can also support joint health from a whole-food foundation. For a broader view of non-pharmaceutical approaches, explore our alternative health coverage.
Frequently Asked Questions
Does glucosamine cause dementia?
The June 2026 study published in Nature Metabolism found a statistical association between glucosamine supplementation and a 25% higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease. The researchers also identified a biological mechanism, hyperglycosylation, where glucosamine fuels overactive sugar-tagging of proteins in the brain, that provides a plausible explanation. However, the study is observational, not a randomized controlled trial, and the researchers state that causal claims require further clinical validation.
Should I stop taking glucosamine?
Do not stop any supplement without first speaking with your healthcare provider. The current evidence suggests that the risk is concentrated in people who already have mild cognitive impairment or dementia. If you have no cognitive symptoms, the immediate risk appears lower, but discussing alternatives with your doctor is reasonable. If you or a loved one has any form of memory decline, this study provides a strong reason to have that conversation promptly.
Is glucosamine FDA approved?
No. Glucosamine is classified as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994. It does not require FDA approval for safety or efficacy before being sold. The FDA can act against supplements only after they are on the market and shown to be unsafe. This regulatory gap is one reason why findings like the 2026 Nature Metabolism study are so important for consumer awareness.
How long does glucosamine stay in your system?
Glucosamine reaches peak blood levels within one to three hours of oral ingestion and is largely cleared from the bloodstream within 24 to 48 hours. However, the 2026 study demonstrated that glucosamine crosses the blood-brain barrier, meaning its metabolic effects on brain tissue may extend beyond its detectable presence in the blood. The duration of its impact on brain glycosylation pathways has not yet been studied in isolation.
Can glucosamine cause memory loss?
In the Alzheimer’s mouse models used in the 2026 study, oral glucosamine directly worsened memory deficits. In human patients with mild cognitive impairment, glucosamine use was associated with a 25% higher rate of progression to dementia. The researchers emphasized that these effects appear to be specific to brains already experiencing neurodegeneration and may not generalize to cognitively healthy individuals. However, the question has not been fully resolved, and the team has called for direct clinical investigation.
What can I take instead of glucosamine for joints?
The strongest evidence-based alternatives include hydrolyzed collagen peptides (supported by a 2026 umbrella review of 113 trials), omega-3 fatty acids from fish oil, curcumin extracted from turmeric, and structured physical therapy and exercise. For a detailed comparison of collagen supplements, formats, and dosing, see our companion article: Do Collagen Supplements Actually Work?
The Bottom Line
The June 2026 Nature Metabolism study from the University of Florida is not the final word on glucosamine safety, and the researchers themselves are clear about that. But it is the most rigorous signal yet that this widely used supplement may carry a serious, previously unrecognized risk, specifically for the millions of people already living with or at risk for cognitive decline.
The key findings:
Glucosamine supplementation was associated with a 25% higher rate of progression from mild cognitive impairment to Alzheimer’s disease. Among patients with established dementia, glucosamine use was linked to a 25% increase in mortality risk over ten years. The biological mechanism, hyperglycosylation driven by increased glycan biosynthesis in the brain, was confirmed in both human tissue and animal models. Blocking this pathway reversed cognitive deficits in Alzheimer’s mice.
More than 40 million Americans take glucosamine each year. The researchers estimate that over one million patients with cognitive impairment may be unknowingly exacerbating their disease progression. That number alone makes this finding urgent enough to share.
If you take glucosamine, talk to your doctor. If someone you care about takes it and has shown any signs of memory decline, share this article with them. The evidence is preliminary, but the stakes, the potential acceleration of one of the most devastating diseases in the world, are too high to ignore.
Billboard Health is your trusted source for practical health and wellness insights. We empower you with evidence-based advice on nutrition, fitness, and overall well-being to help you live your healthiest life.
